Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Crown BioScience Raises $28.8 Million in C Round

publication date: May 4, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Crown BioScience, Inc., a cancer-focused CRO, has closed a $28.8 million Series C round of financing. CrownBio is headquartered in California with labs in Beijing and Taicang City. The company will use the proceeds to expand services in its core cancer drug discovery and translational oncology services, and it will also fund initiatives that expand the company’s services into other therapeutic areas. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...